Hillard C - Search Results

Year	Number of Results
1970	2
1982	1
1983	1
1984	1
1985	1
1986	1
1988	1
1989	1
1990	2
1991	1
1992	2
1993	2
1994	3
1995	5
1997	4
1998	4
1999	4
2000	7
2001	7
2002	2
2003	11
2004	14
2005	21
2006	6
2007	10
2008	15
2009	8
2010	15
2011	9
2012	12
2013	7
2014	10
2015	14
2016	13
2017	16
2018	13
2019	8
2020	17
2021	20
2022	20
2023	11
2024	7

1

Editorial: Therapeutic potential of the cannabinoid CB2 receptor.

Smoum R, Grether U, Karsak M, Vernall AJ, Park F, Hillard CJ, Pacher P. Smoum R, et al. Among authors: hillard cj. Front Pharmacol. 2022 Oct 7;13:1039564. doi: 10.3389/fphar.2022.1039564. eCollection 2022. Front Pharmacol. 2022. PMID: 36278235 Free PMC article. No abstract available.

2

Meet Your Stress Management Professionals: The Endocannabinoids.

deRoon-Cassini TA, Stollenwerk TM, Beatka M, Hillard CJ. deRoon-Cassini TA, et al. Among authors: hillard cj. Trends Mol Med. 2020 Oct;26(10):953-968. doi: 10.1016/j.molmed.2020.07.002. Epub 2020 Aug 28. Trends Mol Med. 2020. PMID: 32868170 Free PMC article. Review.

3

Silicone breast implant rupture: a review.

Hillard C, Fowler JD, Barta R, Cunningham B. Hillard C, et al. Gland Surg. 2017 Apr;6(2):163-168. doi: 10.21037/gs.2016.09.12. Gland Surg. 2017. PMID: 28497020 Free PMC article. Review.

4

Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis.

Hillard CJ, Beatka M, Sarvaideo J. Hillard CJ, et al. Compr Physiol. 2016 Dec 6;7(1):1-15. doi: 10.1002/cphy.c160005. Compr Physiol. 2016. PMID: 28134998 Free PMC article. Review.

5

Stress regulates endocannabinoid-CB1 receptor signaling.

Hillard CJ. Hillard CJ. Semin Immunol. 2014 Oct;26(5):380-8. doi: 10.1016/j.smim.2014.04.001. Epub 2014 May 29. Semin Immunol. 2014. PMID: 24882055 Free PMC article. Review.

6

Amygdalar CB2 cannabinoid receptor mediates fear extinction deficits promoted by orexin-A/hypocretin-1.

Ten-Blanco M, Flores Á, Pereda-Pérez I, Piscitelli F, Izquierdo-Luengo C, Cristino L, Romero J, Hillard CJ, Maldonado R, Di Marzo V, Berrendero F. Ten-Blanco M, et al. Among authors: hillard cj. Biomed Pharmacother. 2022 May;149:112925. doi: 10.1016/j.biopha.2022.112925. Epub 2022 Apr 9. Biomed Pharmacother. 2022. PMID: 35477218 Free article.

7

Endocannabinoids and vascular function.

Hillard CJ. Hillard CJ. J Pharmacol Exp Ther. 2000 Jul;294(1):27-32. J Pharmacol Exp Ther. 2000. PMID: 10871291 Review.

8

The Endocannabinoid Signaling System in the CNS: A Primer.

Hillard CJ. Hillard CJ. Int Rev Neurobiol. 2015;125:1-47. doi: 10.1016/bs.irn.2015.10.001. Epub 2015 Nov 6. Int Rev Neurobiol. 2015. PMID: 26638763 Free PMC article. Review.

9

Endocannabinoids and the Endocrine System in Health and Disease.

Hillard CJ. Hillard CJ. Handb Exp Pharmacol. 2015;231:317-39. doi: 10.1007/978-3-319-20825-1_11. Handb Exp Pharmacol. 2015. PMID: 26408166 Free PMC article. Review.

10

The endocannabinoid system as a putative target for the development of novel drugs for the treatment of psychiatric illnesses.

Hill MN, Haney M, Hillard CJ, Karhson DS, Vecchiarelli HA. Hill MN, et al. Among authors: hillard cj. Psychol Med. 2023 Nov;53(15):7006-7024. doi: 10.1017/S0033291723002465. Epub 2023 Sep 6. Psychol Med. 2023. PMID: 37671673 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

282 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

282 results

Results by year